# TheraVasc

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/theravasc

- Industry: Biotechnology
- Headquarters: Cleveland, US
- Website: www.theravasc.com
- Total disclosed funding: $2.3M
- Latest round: Series A (Sep 27, 2010)
- Investors on record: 5

## About

TheraVasc is based in US and operates as a biotechnology company, develops vascular therapies through the repositioning of drugs for the treatment of vascular disorders.

## Funding rounds

- Series A, Sep 27, 2010, $1.8M — JumpStart, Portal Capital, North Coast Ventures, Physicians Investment Group, Rev1 Ventures
- Seed, Jan 6, 2010, $0.5M — JumpStart, Portal Capital

## Investors

- JumpStart (https://capitalatlas.ai/funds/jumpstart) — Seed, Series A
- Portal Capital (https://capitalatlas.ai/funds/portal-capital) — Seed, Series A
- North Coast Ventures (https://capitalatlas.ai/funds/north-coast-ventures) — Series A
- Physicians Investment Group — Series A
- Rev1 Ventures (https://capitalatlas.ai/funds/rev1-ventures) — Series A